Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute

Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute CHELMSFORD, Mass., Jan. 12, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS)  announced today that GENEWIZ, the Company’s genomics analysis business, has been awarded one of six  Genome Characterization Center Indefinite Delivery Indefinite Quantity (IDIQ) contracts from the National Cancer Institute (NCI). The NCI,... Read more

Development of Novel Quantum Sensors with New FE-SEM Technology

The Center for Applied Quantum Technology (ZAQuant) receives the world’s first ZEISS GeminiSEM 560 installation The precise measurement of physical quantities is a driving force for almost all technical progress. The key mission at the Center for Applied Quantum Technology (ZAQuant) at the University of Stuttgart (Germany) is the development of novel quantum sensors for... Read more

New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). This new and integrated bioinformatics solution provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment. “Illumina... Read more

Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling

SAN DIEGO–(BUSINESS WIRE)–With genetic sequencing at the forefront of precision medicine, Illumina (NASDAQ: ILMN) is pleased to announce a portfolio of new and expanded oncology partnerships that further the company’s commitment to develop standardized, globally distributable tools for precision oncology. Speaking today at the 39th Annual J.P. Morgan Healthcare Conference in San Francisco, California, Illumina... Read more

Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer

Basel, 11 January 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient. The image analysis algorithms use artificial intelligence to support... Read more

Roche’s Xofluza approved by the European Commission for the treatment of influenza, the first new influenza antiviral for patients in almost 20 years

Basel, 11 January 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 years and above. In addition, the EC has approved Xofluza for post-exposure prophylaxis of influenza in individuals aged 12 years and above.... Read more

GHz-Class NMR Opens New Scientific Research Window for Discoveries and Novel Insights in Functional Structural Biology and Disease Biology

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that three world-leading institutions are now accelerating their research into functional structural biology and human disease with new Bruker ultra-high field nuclear magnetic resonance (NMR) spectrometers installed in 2020. Novel GHz-class NMR technology enables advanced research to obtain structural, functional and binding information of intrinsically disordered... Read more

Thermo Fisher Scientific Offers Financial Flexibility with New Managed Equipment Solutions

Thermo Fisher Scientific Offers Financial Flexibility with New Managed Equipment Solutions New model for instrument and equipment procurement offers customers subscription-based access to technology, and associated consumables, services and support WALTHAM, Mass., Jan. 6, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of Managed Equipment... Read more

HORIBA Scientific announces an enhanced OEM RAMAN Spectral Engine with a new Deep-cooled VIS-NIR CCD for reliable process analytical measurements

01/06/2021 Affordable Raman engine for high volume OEM customers with unmatched detection limit PISCATAWAY, NJ January 6, 2021 – HORIBA Scientific, global leader in OEM Gratings, Miniature spectrometers and Scientific Camera systems and solutions, just announced its new CiCi-Raman engine designed for high volume OEM industrial customers. The CiCi-Raman-785 is a high performance spectrometer featuring an aberration-corrected... Read more